Gregory Duncan's most recent trade in Dogwood Therapeutics Inc. was a trade of 330,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 330,000 | 330,000 | - | - | Stock Option (right to buy) | |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2026 | 30,453 | 68,786 (0%) | 0% | 0 | Common Stock | |
| Dogwood Therapeutics Inc | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 460,000 | 460,000 | - | - | Stock Option (right to buy) | |
| CorMedix Inc | Gregory Duncan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 16 Sep 2025 | 13,333 | 38,333 (0%) | 0% | 8.3 | 110,931 | Common Stock |
| CorMedix Inc | Gregory Duncan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 13,333 | 6,667 | - | - | Stock Option (Right to Buy Common Stock) | |
| Dogwood Therapeutics Inc | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Dogwood Therapeutics Inc | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 138,835 | 138,835 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc | Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 17 Aug 2023 | 25,000 | 57,461 | - | 1.2 | 31,245 | Common Stock |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) |